期刊文献+

IL-15对CIK细胞的扩增及细胞表型的影响 被引量:1

The Effect of Interleukin-15 on the Proliferation of Cytokine-Induced Killers and on the Expression of Cell Surface Markers
下载PDF
导出
摘要 目的探索IL-15对CIK细胞的扩增及细胞表型的影响。方法以常规培养的CIK细胞为对照,观察培养体系中加入IL-15后CIK细胞的扩增情况,并用流式细胞仪检测其表面标志的变化。结果①IL-15组的扩增速度大于常规培养组,从培养14天起两组扩增倍数的差异有统计学意义(P<0.05);②培养后IL-15组的CD3+ CD56+细胞比例及NKG2D表达率均高于常规培养组,于培养14天起,两组差异均有统计学意义(P<0.05)。结论 IL-15可增加CIK细胞的增生能力,并增加CD3+ CD56+细胞及NKD2D的表达率。 ObjectiveTo investigate the effect of interleukin-15 (IL-15) on the proliferation of cytokine-induced killers (CIKs) and on the expression of cell surface markers.MethodsMononuclear cells were isolated from peripheral blood of 15 healthy volunteers by Ficoll density gradient centrifugation, and then were induced to differentiating into CIKs in the presence of various cytokines with or without IL-15. Cells were harvested each week for 4 weeks starting with day 0, and viable cell number was determined using the Trypan blue dye-exclusion method. The levels of cell surface markers CD3, CD56, and NKG2D were measured by flow cytometry. ResultsCIKs in the IL-15-treated group had a significantly higher proliferation rate from day 14 than those in the group without IL-15 treatment (P〈0.05). Moreover, IL-15 treatment resulted in a significantly higher proportion of CD3+CD56+ cells as well as enhanced expression of NKG2D as compared to the IL-15-untreated group (P〈0.05).ConclusionIL-15 increases the proliferation of CIKs and enhances the expression of NKG2D on the surface of CD3+CD56+CIKs.
出处 《医学研究杂志》 2010年第7期71-73,共3页 Journal of Medical Research
基金 福建省泉州市科技局资助项目(2007Z37) 2008年福建省泉州市组织部优秀人才培养专项经费资助
关键词 白介素15 细胞因子诱导杀伤细胞 IL - 15 Cytokine induced killers
  • 相关文献

参考文献11

  • 1Schmidt Wolf GD,Negrin RS,Schmidt Wolf IGH.Activated T cells and cytokine induced CD3+CD56+ killer cells[J].Ann Hematol,1997,74(2):51-56.
  • 2Leemhuis T,Wells S,Scheffold C,et al.A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma[J].Biology of Blood and Marrow Transplantation,2005,11(3):181-187.
  • 3陈明水,陈强,叶韵斌,李洁羽,陈淑萍,周智锋.CIK细胞的体外扩增及其抗肿瘤特性的研究[J].福建医药杂志,2004,26(6):162-164. 被引量:8
  • 4Introna M,Borleri G,Conti E,et al.Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after ailogeneic stem cell transplantation:a phase I study[J].Haematologica,2007,92(7):952-959.
  • 5Ryosei N,Jeanette B,Andreas B,et al.In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity[J].Blood,2008,112(8):2563-2574.
  • 6Chan JK,Hamilton CA,Cheung MK,et al.Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies:A Preclinical Study[J].Clinical Cancer Research March,2006,12(6):1859-1867.
  • 7Verneris MR,Karami M,Baker J,et al.Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells[J].Blood,2004,103(20):3065-3072.
  • 8Dunne J,Lynch S,O′Farrelly C,et al.Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.J Immunol,2001,167:3129-3138.
  • 9ZhangC,ZhangJ,NiuJ,et al.Interleukin-15 improves cytotoxicity of natural killer cells via up-regulatingNKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.Cytokine,2008,42:128-136.
  • 10Boyiadzis M,Memon S,Carson J.Up-regulationof NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 Levels.BiolBloodMarrowTransPlant,2008,14:290-300.

二级参考文献8

  • 1Schmidt Wolf GD,Negrin RS,Schmidt Wolf IGH.Activated T cells and cytokine-induced CD3+CD56+killer cells.J Ann Hematol,1997,74(2):51~56.
  • 2Foseph C.Alvaras,Yeh-Ching Linn,Ernest G.Hope,et al.Expansion of cytotoxic CD3+CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation.J Biology of Blood and Marrow Transplantation,2001,7(2):216~222.
  • 3Lu PH,Negrin RS.A novel population of expanded human CD3+CD56+ cells devived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.J Immunol,1994,153(4):1687~1696.
  • 4Schmidt-Wolf IGH,Lefrerov P,Johnson V,et al.Population of large number of T cells with natural killer marker.J Haematology,1994,87:453.
  • 5Yu YY,Si CW,Tian XL,et al.Effect of cytokines on liver necrosis.World J Gastroentero,1998,4:311~313.
  • 6Schmidt Wlof IGH,Lefterova P,Johnson V,et al.Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells.Cell Immunol,1996,169:85~90.
  • 7Augsto C,Gianni G,Barbara J,et al.Long-term growth of lymphokine-activeated killer(LAK)cells:Role ofanti-CD3,β-IL-1,IFN-γand-β.J Immunol,1987,138:2728~2831.
  • 8于津浦,任秀宝,刘虹,张澎,郝希山.CIK细胞中CD4^+T细胞亚群抗肿瘤免疫活性[J].中国肿瘤生物治疗杂志,2003,10(2):126-129. 被引量:9

共引文献7

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部